therapeutics 相關
廣告
搜尋結果
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
Bloomberg· 2 日前... Asahi Kasei Corp. plans to buy Swedish biotechnology firm Calliditas Therapeutics< ... ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 7 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal
Bloomberg· 2 日前Have a confidential tip for our reporters? Johnson & Johnson agreed to pay $1.25 billion for ...
美股前瞻 | 三大股指期貨漲跌不一 美股今起進入“T+1“時代
阿思達克財經網· 2 日前盤前市場動向1. 5月28日(週二)美股盤前,美股三大股指期貨漲跌不一。截至發稿,道指期貨跌0.12%,標普5...
Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion
Reuters· 2 日前, opens new tab for about 11.8 billion Swedish crowns ($1.1 billion) as part of a plan to ...
產後抑鬱|全球首款產後抑鬱症口服藥面世 病人服藥數天已改善:像剛睡醒 - 香港經濟日報 - TOPick - ...
TOPick - 香港經濟日報· 2 日前【產後抑鬱/藥物/全球首款/藥廠/口服藥/懷孕/產前產後】產後抑鬱新治療方法!由美國藥廠研發的全球第一款治療產後抑鬱症的口服藥物Zurzuvae,早前獲美國批 ...
therapeutics 相關
廣告